Package 17772-121-07

{"route": ["ORAL"], "spl_id": "41c1a4d4-ff5a-00b4-e063-6294a90a6ec7", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0317772123012", "0317772121018", "0317772122015"], "unii": ["VZI5B1W380"], "rxcui": ["1365653", "1365660", "1365842", "1365844", "1365847", "1365850"], "spl_set_id": ["aa610e56-1d1d-11e1-8bc2-0800200c9a66"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Supernus Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (17772-121-01)", "package_ndc": "17772-121-01", "marketing_start_date": "20130117"}, {"sample": true, "description": "7 TABLET in 1 BOTTLE (17772-121-07)", "package_ndc": "17772-121-07", "marketing_start_date": "20230701"}, {"sample": true, "description": "5 TABLET in 1 BLISTER PACK (17772-121-10)", "package_ndc": "17772-121-10", "marketing_start_date": "20130117"}], "brand_name": "OXTELLAR XR", "product_id": "17772-121_41c1a4d4-ff5a-00b4-e063-6294a90a6ec7", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "17772-121", "generic_name": "OXCARBAZEPINE", "labeler_name": "Supernus Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXTELLAR XR", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "NDA202810", "marketing_category": "NDA", "marketing_start_date": "20130117", "listing_expiration_date": "20261231"}